交易中 08-08 13:49:48
0.000
0.00%
Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company, announced it will release its second-quarter 2025 financial results on August 14, 2025, followed by a webcast/teleconference at 4:30 p.m. ET. The company, focused on developing targeted therapies for oncology, is currently conducting multiple clinical trials, including the Phase 3 VIKTORIA-1 trial for HR+/HER2- advanced breast cancer and the Phase 1/2 CELC-G-201 trial for metas...
08-07 11:05
证券之星消息,截至2025年7月28日收盘,时富投资(01049.HK)报收于1.03港元,上涨0.98%,成交量1.2万股,成交额1.23万港元。
07-28 17:47
港交所8月4日下调港股最低上落价位!美图公司料上半年经调整净利润同比增长65%至72%;比亚迪拟每10股送红股8股>>
07-22 08:01
时富投资(01049)已开发名为Quantphemes的人工智能(AI)赋能量化交易及社群平台……
07-21 23:01
时富金融服务集团(00510.HK)和时富投资(01049.HK)联合公布,时富投资集团已开发名为Quantphemes的人工智能(AI)赋能量化交易及社群平台。
07-21 17:32
时富金融服务集团(00510)和时富投资(01049)联合公布,时富投资集团已开发...
07-21 16:45
Celestica Inc. will host its second quarter 2025 financial results conference call on July 29, 2025, at 8:00am ET. The financial results will be released after market close on July 28, 2025. Participants can join the live webcast via the provided link, and a recorded version will be available on www.celestica.com approximately two hours after the call. For more information, contact Celestica Investor Relations at clsir@celestica.com.
07-09 21:48
证券之星消息,截至2025年7月9日收盘,时富投资(01049.HK)报收于1.15港元,上涨2.68%,成交量33.4万股,成交额39.33万港元。
07-09 17:41
时富投资(01049.HK)发布公告,一般授权认购协议所载所有先决条件均已获达成,于2025年6月19日已完成发行本金总额为2000万港元的一般授权可换股债券。
06-19 17:30